1NQ9 image
Deposition Date 2003-01-21
Release Date 2003-09-30
Last Version Date 2024-10-16
Entry Detail
PDB ID:
1NQ9
Keywords:
Title:
Crystal Structure of Antithrombin in the Pentasaccharide-Bound Intermediate State
Biological Source:
Source Organism:
(Taxon ID: )Homo sapiens (Taxon ID: 9606)
Method Details:
Experimental Method:
Resolution:
2.60 Å
R-Value Free:
0.25
R-Value Work:
0.20
Space Group:
P 1 21 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Antithrombin-III
Gene (Uniprot):SERPINC1
Chain IDs:A (auth: I), B (auth: L)
Chain Length:432
Number of Molecules:2
Biological Source:Homo sapiens
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
ASN A ASN GLYCOSYLATION SITE
Ligand Molecules
Peptide-like Molecules
PRD_900031
Primary Citation
Crystal Structure of Antithrombin in a Heparin-Bound Intermediate State
Biochemistry 42 8712 8719 (2003)
PMID: 12873131 DOI: 10.1021/bi034524y

Abstact

Antithrombin is activated as an inhibitor of the coagulation proteases through its specific interaction with a heparin pentasaccharide. The binding of heparin induces a global conformational change in antithrombin which results in the freeing of its reactive center loop for interaction with target proteases and a 1000-fold increase in heparin affinity. The allosteric mechanism by which the properties of antithrombin are altered by its interactions with the specific pentasaccharide sequence of heparin is of great interest to the medical and protein biochemistry communities. Heparin binding has previously been characterized as a two-step, three-state mechanism where, after an initial weak interaction, antithrombin undergoes a conformational change to its high-affinity state. Although the native and heparin-activated states have been determined through protein crystallography, the number and magnitude of conformational changes render problematic the task of determining which account for the improved heparin affinity and how the heparin binding region is linked to the expulsion of the reactive center loop. Here we present the structure of an intermediate pentasaccharide-bound conformation of antithrombin which has undergone all of the conformational changes associated with activation except loop expulsion and helix D elongation. We conclude that the basis of the high-affinity state is not improved interaction with the pentasaccharide but a lowering of the global free energy due to conformational changes elsewhere in antithrombin. We suggest a mechanism in which the role of helix D elongation is to lock antithrombin in the five-stranded fully activated conformation.

Legend

Protein

Chemical

Disease

Primary Citation of related structures